HOYA’s revenues increase 19.9% to 115,224 million yen in Q4 2014

HOYA Corporation (TOKYO:7741) today announced financial results for the fourth quarter and full-year ended March 31, 2014. During the quarter, revenues increased 19.9% to 115,224 million yen compared with the same period last year. Profit before tax totaled 19,892 million yen, while profit for the term amounted to 12,758 million yen, a decline of 37.1% and 47.5% from the previous year, respectively. In the same period, the previous year included insurance income of 14,275 million yen as compensation for damage suffered from flooding in Thailand. Excluding this one-off factor, profit before tax increased from the same period last year.

For the fiscal year ended March 31, 2014, revenues totaled 427,575 million yen, up 14.8% year on year. Profit before tax was 85,486 million yen and profit for the term was 60,140 million yen, a decline of 6.3% and 16.9% respectively year on year.

"Both revenues and profits of the eyeglass lens business fully recovered from the flooding in Thailand in the fourth quarter. We are planning to increase production capacity by opening a new plant this year." said Hiroshi Suzuki, chief executive officer of HOYA. "Sales for medical endoscope business grew at a healthy pace, and we are accelerating the growth by promoting newly introduced high-end series, ultrasound endoscopes and other unique products."

HOYA also announced year-end dividends forecast of 45 yen per share, a 10 yen increase compared with year-end dividends last year. The annual dividends, including the interim dividends of 30 yen per share, will amount to 75 yen per share. The official decision will be made at the Board of Directors meeting in late May.

Source:

Hoya 

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.